Medical AI Platform

Clinical-Grade AI Infrastructure

End-to-end AI infrastructure designed for medical, biomedical, and life-science workloads where reliability isn't optional—it's foundational.

HIPAA-Aligned
FDA-Pathway Ready
Clinical Data Isolation

Who We Serve

Healthcare organizations requiring enterprise-grade AI with regulatory compliance

Hospitals & Health Systems

Diagnostic imaging, clinical decision support, patient care optimization

Medical Research

AI-driven research, clinical trials, biomedical data analysis

Pharma & Life Sciences

Drug discovery, molecular modeling, clinical outcome prediction

Genomics Labs

Sequence analysis, variant calling, precision medicine research

Why Genox AI Medical?

Healthcare AI isn't just about accuracy—it's about auditability, reproducibility, and regulatory compliance.

We provide end-to-end ML pipelines specifically architected for medical workloads: from data ingestion with clinical isolation, through preprocessing and RAG/ETL, to GPU-accelerated training and production inference.

Every model run is tracked with complete dataset lineage. Every training job is reproducible. Every inference is auditable. This isn't optional in healthcare—it's foundational.

HIPAA-Compliance by Design

Clinical data isolation, encryption at rest and in transit, audit logging, and access controls meeting HIPAA technical safeguards.

FDA-Pathway Readiness

Built-in validation frameworks, version control, and documentation systems designed to support FDA submission requirements.

Complete Data Lineage

Track every dataset, preprocessing step, and model version. Reproduce any training run. Prove compliance.

Real-World Applications

From diagnostic imaging to drug discovery—AI infrastructure for mission-critical healthcare

Medical Imaging & Diagnostics

Computer Vision for Radiology: Train and deploy AI models for X-ray, CT, MRI analysis with GPU-accelerated inference and clinical-grade accuracy validation.

Pathology AI: Whole-slide image analysis for cancer detection, tissue classification, and diagnostic support with full audit trails.

→ Typical ROI: 40-60% reduction in diagnostic turnaround time

Genomics & Bioinformatics

Sequence Analysis: Variant calling, genome assembly, and annotation pipelines with massive parallel processing capabilities.

Precision Medicine: AI-driven patient stratification, treatment response prediction, and personalized therapy recommendations.

→ Infrastructure scales from single samples to population-level studies

Clinical Decision Support

Evidence-Based AI: Deploy models trained on clinical evidence for diagnosis assistance, treatment planning, and outcome prediction.

Real-Time Alerting: Patient deterioration prediction, sepsis detection, and early warning systems integrated with EHR workflows.

→ Designed for HL7 FHIR integration and seamless EHR connectivity

Drug Discovery & Development

Molecular Modeling: AI-accelerated protein structure prediction, drug-target interaction analysis, and compound screening.

Clinical Trials Optimization: Patient selection, endpoint prediction, and adverse event detection using advanced ML pipelines.

→ GPU-intensive workloads with priority scheduling and cost optimization

What Sets Us Apart

Purpose-built infrastructure for healthcare AI—not retrofitted cloud services

01
Continuous Heavy Training

Priority-based GPU scheduling with Kueue orchestration. Train large medical AI models continuously while maintaining cost efficiency through spot instance arbitration and smart resource allocation.

02
Clinical Data Isolation

Namespace-level isolation with dedicated persistent volumes. Each medical project operates in a completely isolated environment with strict access controls and zero data leakage between workloads.

03
Reproducible Science

Every training run is versioned and reproducible. Complete dataset lineage tracking ensures you can prove exactly what data trained which model—critical for FDA submissions and clinical validation.

Development Status

Genox AI Medical is currently in pre-production development. We are building towards FDA compliance pathways and HIPAA certification with expected initial release in Q3 2026.

Our infrastructure is designed for clinical-grade reliability from day one—architecting compliance into the foundation, not bolting it on afterward.

Pre-Production Development
Q3 2026 Target Launch